Associated Papers
Establishment and validation of a gene mutation-based risk model for predicting prognosis and therapy response in acute myeloid leukemia.
Liu Y et al.
Heliyon, 2024
38831838 (PubMed )
Supplement: mmc3.xlsx › Sheet1
In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.
Anekpuritanang T et al.
Blood Advances, 2021
34559205 (PubMed )
Supplement: advancesADV2021004983-suppl1.pdf
Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.
Wang M et al.
Oncotarget, 2017
Select a paper to view details